Hydroxychloroquine is now a schedule H1 drug. So, pharmacists should now sell this medicine only when customers produce a valid prescription.
The Ministry of Health and Family Welfare issued a Gazette Notification G.S.R. 219(E) on 26th March, 2020. Pharmacists should sell Hydroxychloroquine as a Schedule a H1 drug, in accordance with the Drugs and Cosmetics Rules, 1945.
“The Central Government is satisfied that the drug ‘Hydroxychloroquine’ is essential to meet the requirements of emergency arising due to pandemic COVID-19 and in the public interest, it is necessary and expedient to regulate and restrict the sale and distribution of the drug ‘Hydroxychloroquine’ and preparation based thereon for preventing their misuse,” reads the Gazette notification.
“Now, therefore, in exercise of the powers conferred by Section 26B of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government hereby directs that sale by retail of any preparation containing the drug Hydroxychloroquine shall be in accordance with the conditions for sale of drugs specified in Schedule H1 to the Drugs and Cosmetics Rules, 1945,” stated the Gazette notification.
PepPill Store has also changed the Drug Schedule of Hydroxychloroquine to Schedule H1 in its drug database. The product for pharmacies is always up-to-date, helping pharmacies to comply with the latest Drug Scheduling standards. So, pharmacists wouldn’t have to worry on manually working on the Drug Compliance part. And, PepPill Store is here to take care of it all.
Want to know more about PepPill?
Send us your contact details, and we’ll contact you within 1 business day.